Novocure Announces 25 Abstracts on Tumor Treating Fields Therapy at Society for Neuro-Oncology 2022 Annual MeetingBusiness Wire • 11/17/22
Novocure Opens Office in Montreal to Expand and Support Growing Business in CanadaBusiness Wire • 11/15/22
Novocure Announces 11 Presentations on Tumor Treating Fields in Multiple Solid Tumor Types at the American Society for Radiation Oncology 2022 Annual MeetingBusiness Wire • 10/21/22
Novocure Announces Review Article of Anti-Cancer Mechanisms of Action of Tumor Treating Fields Published in Journal of Molecular Cell BiologyBusiness Wire • 10/20/22
Novocure Launches Campaign to Drive Awareness and Understanding of Tumor Treating Fields TherapyBusiness Wire • 10/20/22
Novocure Announces Creation of U.S. CNS Cancers Franchise Intended to Renew Focus on Growth in Glioblastoma BusinessBusiness Wire • 09/21/22
Novocure Ltd (NVCR) CEO Asaf Danziger on Q2 2022 Results - Earnings Call TranscriptSeeking Alpha • 07/28/22
Novocure Announces Recipients of 4th Annual AACR-Novocure Grants for Tumor Treating Fields Research ProgramBusiness Wire • 07/27/22